STOCK TITAN

MKS Inc (MKSI) Rule 144 Notice — 838 Shares Planned Sale on NASDAQ

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for MKSI (MKS Inc). The filing reports a proposed sale of 838 common shares through Fidelity Brokerage Services LLC with an aggregate market value of $103,912, and an approximate sale date of 09/18/2025 on NASDAQ. The shares were acquired via restricted stock vesting on 02/15/2021 (241 shares) and 02/15/2022 (597 shares) and paid as compensation. The filing also discloses a prior sale by James Schreiner of 957 shares on 07/07/2025 for $98,035.08. The form includes the standard attestation that the seller does not possess undisclosed material adverse information about the issuer.

Positive

  • Regulatory compliance: The filing discloses acquisition dates, nature of acquisition, broker, planned sale date, and market value as required by Rule 144.
  • Transparency on provenance: Shares to be sold are identified as compensation from restricted stock vesting with specific acquisition dates.

Negative

  • Insider selling activity: The filing shows planned disposal of 838 shares and a recent sale of 957 shares, which investors may interpret as insider liquidity.
  • Limited issuer context: The form provides no operational or financial information about the issuer and no disclosure of any 10b5-1 plan adoption date.

Insights

TL;DR: Routine insider sale notice; confirms planned sale of 838 shares and prior sale of 957 shares.

The filing is a standard Rule 144 notice showing an insider or related person intends to sell 838 common shares worth $103,912 on or about 09/18/2025 via Fidelity. The shares originated from restricted stock vesting in 2021 and 2022 and were compensation, which is consistent with typical post-vesting dispositions. The disclosure of a recent sale of 957 shares on 07/07/2025 for $98,035.08 provides additional context on recent insider activity. There are no financial performance metrics or new corporate actions disclosed.

TL;DR: Compliance filing demonstrates disclosure of insider transactions but contains limited issuer context.

The submission meets Rule 144 reporting requirements by documenting acquisition dates, nature of acquisition, and planned sale details including broker and exchange. It includes the required representation regarding material non-public information. The filing lacks additional issuer-specific details such as the identity of the person for whose account the sale is to be made (beyond past-seller information) and contains no commentary on trading plans or 10b5-1 adoption dates.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the MKSI Form 144 report?

The filing reports a proposed sale of 838 common shares on 09/18/2025 via Fidelity with an aggregate market value of $103,912.

How were the shares to be sold acquired?

The shares were acquired as restricted stock vesting: 241 shares on 02/15/2021 and 597 shares on 02/15/2022, recorded as compensation.

Did the filing disclose recent sales by the same person?

Yes. The filing shows a prior sale by James Schreiner of 957 shares on 07/07/2025 for $98,035.08.

On which exchange will the shares be sold?

The planned sale is reported to occur on NASDAQ through Fidelity Brokerage Services LLC.

Does the filing state whether a 10b5-1 trading plan was used?

No. The filing includes the standard notice and a field for plan adoption date, but no 10b5-1 plan adoption date or instruction date is provided.
MKS Inc.

NASDAQ:MKSI

View MKSI Stock Overview

MKSI Rankings

MKSI Latest News

MKSI Latest SEC Filings

MKSI Stock Data

14.68B
66.55M
Scientific & Technical Instruments
Industrial Instruments for Measurement, Display, and Control
Link
United States
ANDOVER